1. Home
  2. AMPH vs PHIN Comparison

AMPH vs PHIN Comparison

Compare AMPH & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • PHIN
  • Stock Information
  • Founded
  • AMPH 1996
  • PHIN 2023
  • Country
  • AMPH United States
  • PHIN United States
  • Employees
  • AMPH N/A
  • PHIN N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • PHIN
  • Sector
  • AMPH Health Care
  • PHIN
  • Exchange
  • AMPH Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • AMPH 1.7B
  • PHIN 1.8B
  • IPO Year
  • AMPH 2014
  • PHIN N/A
  • Fundamental
  • Price
  • AMPH $36.41
  • PHIN $50.58
  • Analyst Decision
  • AMPH Buy
  • PHIN Buy
  • Analyst Count
  • AMPH 4
  • PHIN 2
  • Target Price
  • AMPH $60.33
  • PHIN $53.50
  • AVG Volume (30 Days)
  • AMPH 672.6K
  • PHIN 355.7K
  • Earning Date
  • AMPH 02-26-2025
  • PHIN 02-13-2025
  • Dividend Yield
  • AMPH N/A
  • PHIN 1.98%
  • EPS Growth
  • AMPH 17.38
  • PHIN N/A
  • EPS
  • AMPH 3.01
  • PHIN 2.34
  • Revenue
  • AMPH $723,549,000.00
  • PHIN $3,452,000,000.00
  • Revenue This Year
  • AMPH $16.76
  • PHIN N/A
  • Revenue Next Year
  • AMPH $8.00
  • PHIN $1.04
  • P/E Ratio
  • AMPH $12.09
  • PHIN $21.56
  • Revenue Growth
  • AMPH 20.33
  • PHIN N/A
  • 52 Week Low
  • AMPH $34.60
  • PHIN $29.11
  • 52 Week High
  • AMPH $56.45
  • PHIN $57.23
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.93
  • PHIN 53.57
  • Support Level
  • AMPH $34.60
  • PHIN $49.88
  • Resistance Level
  • AMPH $36.66
  • PHIN $52.44
  • Average True Range (ATR)
  • AMPH 1.41
  • PHIN 1.34
  • MACD
  • AMPH 0.29
  • PHIN 0.35
  • Stochastic Oscillator
  • AMPH 43.54
  • PHIN 69.59

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About PHIN PHINIA Inc.

Phinia Inc is a leader in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles and industrial applications, and light vehicles. It is a global supplier to most major original equipment manufacturers (OEMs) and offers a wide range of original equipment service (OES) solutions and remanufactured products as well as an expanded range of products for the independent (non-OEM) aftermarket. Phinia has an extensive original equipment portfolio of advanced fuel injection systems, fuel delivery modules, canisters, starters, alternators, sensors, electronic control modules, and associated software.

Share on Social Networks: